60 Degrees Pharma Expands ARAKODA Access via Runway Health Partnership
Event summary
- 60 Degrees Pharma has made ARAKODA (tafenoquine) available for malaria prevention via the Runway Health telehealth platform.
- The once-weekly, broad-spectrum malaria preventive is now purchasable online for U.S. travelers.
- ARAKODA requires a prescription, which can be obtained through Runway Health's licensed healthcare professionals.
- The medication is FDA-approved for adults aged 18 and older traveling to malaria-endemic regions.
The big picture
60 Degrees Pharma's partnership with Runway Health aligns with the broader trend of telehealth expansion in the pharmaceutical sector. By making ARAKODA more accessible, the company aims to capture a larger share of the travel health market, particularly among travelers to malaria-endemic regions. The strategic move could also pressure competitors to enhance their digital health offerings.
What we're watching
- Market Penetration
- How the online availability of ARAKODA will affect adoption rates among travelers.
- Regulatory Compliance
- Whether the telehealth prescription model will face regulatory scrutiny.
- Competitive Dynamics
- The pace at which competitors respond with similar telehealth offerings for malaria prevention.
Related topics